OPKO Health, Inc.
General ticker "OPK" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $928.3M (TTM average)
OPKO Health, Inc. follows the US Stock Market performance with the rate: 3.4%.
Estimated limits based on current volatility of 3.6%: low 1.38$, high 1.49$
Factors to consider:
- Total employees count: 2997 (-23.7%) as of 2024
- US accounted for 76.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operating losses and lack of profitability, Product defects, Dependence on CEO, Regulatory and compliance, Geopolitical risks
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.02$, 1.89$]
- 2026-12-31 to 2027-12-31 estimated range: [1.13$, 2.04$]
Financial Metrics affecting the OPK estimates:
- Positive: with PPE of -4.3 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0 <= 0.28
- Positive: Investing cash flow per share per price, % of 23.57 > -0.60
- Positive: Shareholder equity ratio, % of 65.63 > 64.29
Short-term OPK quotes
Long-term OPK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $863.50MM | $713.14MM | $708.46MM |
| Operating Expenses | $1,020.52MM | $865.21MM | $825.86MM |
| Operating Income | $-157.02MM | $-152.06MM | $-117.41MM |
| Non-Operating Income | $-27.30MM | $141.70MM | $-123.95MM |
| Interest Expense | $13.51MM | $47.47MM | $108.46MM |
| R&D Expense | $89.59MM | $105.21MM | $124.03MM |
| Income(Loss) | $-184.32MM | $-10.36MM | $-241.36MM |
| Taxes | $4.44MM | $42.84MM | $-15.71MM |
| Other Income(Loss) | $-0.11MM | $-0.02MM | $-0.03MM |
| Net Income(Loss)* | $-188.86MM | $-53.22MM | $-225.68MM |
| Stockholders Equity | $1,389.22MM | $1,365.45MM | $1,267.96MM |
| Inventory | $65.70MM | $56.80MM | $65.82MM |
| Assets | $2,011.70MM | $2,200.21MM | $1,931.94MM |
| Operating Cash Flow | $-28.20MM | $-183.49MM | $-178.54MM |
| Capital expenditure | $16.27MM | $25.01MM | $12.28MM |
| Investing Cash Flow | $-18.20MM | $352.21MM | $230.30MM |
| Financing Cash Flow | $-11.30MM | $184.17MM | $-118.06MM |
| Earnings Per Share** | $-0.25 | $-0.08 | $-0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.